CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade TransMedics Group Inc - TMDX CFD

68.45
2.74%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.19
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02354 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02354%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001318 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001318%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 70.38
Open 68.95
1-Year Change -6.77%
Day's Range 67.75 - 69.57
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2025 68.45 -1.06 -1.52% 69.51 70.20 67.74
Mar 27, 2025 70.38 0.74 1.06% 69.64 71.89 69.00
Mar 26, 2025 70.21 -0.74 -1.04% 70.95 73.38 70.05
Mar 25, 2025 70.75 -0.50 -0.70% 71.25 71.92 69.48
Mar 24, 2025 71.42 1.21 1.72% 70.21 72.65 69.35
Mar 21, 2025 69.00 1.19 1.75% 67.81 70.41 66.45
Mar 20, 2025 68.76 -0.64 -0.92% 69.40 71.47 67.82
Mar 19, 2025 70.19 1.28 1.86% 68.91 72.13 68.81
Mar 18, 2025 68.87 2.73 4.13% 66.14 69.00 65.02
Mar 17, 2025 67.65 -0.71 -1.04% 68.36 69.50 67.19
Mar 14, 2025 68.40 3.00 4.59% 65.40 68.64 65.40
Mar 13, 2025 64.26 -2.69 -4.02% 66.95 67.63 62.57
Mar 12, 2025 67.04 -2.17 -3.14% 69.21 69.30 66.07
Mar 11, 2025 67.60 1.60 2.42% 66.00 68.54 65.45
Mar 10, 2025 65.88 0.63 0.97% 65.25 67.87 64.41
Mar 7, 2025 67.40 2.45 3.77% 64.95 68.02 63.50
Mar 6, 2025 65.24 1.38 2.16% 63.86 66.18 62.03
Mar 5, 2025 67.31 -1.84 -2.66% 69.15 69.49 66.29
Mar 4, 2025 68.91 3.37 5.14% 65.54 69.70 63.23
Mar 3, 2025 69.27 -7.00 -9.18% 76.27 76.94 68.39

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

TransMedics Group, Inc. Company profile

About TransMedics Group Inc

TransMedics Group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, TransMedics Group Inc revenues increased 18% to $30.3M. Net loss increased 54% to $44.2M. Revenues reflect OCS Lung net revenue segment increase of 72% to $10.7M, OCS Heart net revenue segment increase of 25% to $17.7M, United States segment increase of 14% to $21.9M, All other countries segment increase of 31% to $8.4M.

Industry: Advanced Medical Equipment & Technology (NEC)

200 Minuteman Road
ANDOVER
MASSACHUSETTS 01810
US

People also watch

Gold

3,117.89 Price
+1.040% 1D Chg, %
Long position overnight fee -0.0170%
Short position overnight fee 0.0088%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

2.10 Price
-2.220% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01046

ETH/USD

1,818.62 Price
+0.090% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

BTC/USD

82,236.00 Price
-0.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading